Zobrazeno 1 - 10
of 52
pro vyhledávání: '"K. Pawlak-Bus"'
Publikováno v:
Annals of the Rheumatic Diseases. 81:967-967
BackgroundAberrant immune response is hallmark of severe COVID-19, irrespectively from viral replication. Immunomodulatory therapies such as interleukin-6 (IL-6) receptor inhibitors were proven to be beneficial in reducing in-hospital mortality1. Yet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38ad823c08cff197118821152ce5ca19
https://doi.org/10.1136/annrheumdis-2022-eular.4204
https://doi.org/10.1136/annrheumdis-2022-eular.4204
Autor:
Mariusz Puszczewicz, Slawomir Michalak, Alicja Kalinowska-Lyszczarz, Anna Pietrzak, Wojciech Kozubski, Włodzimierz Paprzycki, K Pawlak-Bus, Piotr Leszczyński, Mikolaj A. Pawlak
Publikováno v:
Lupus. 27:1624-1635
Differentiation of systemic lupus erythematosus (SLE) from multiple sclerosis (MS) can be challenging, especially when neuropsychiatric (NP) symptoms are accompanied by white matter lesions in the brain. Given the lack of discriminative power of curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38decccd6a612ff55360e16d47eba460
https://doi.org/10.1177/0961203318781004
https://doi.org/10.1177/0961203318781004
Publikováno v:
Annals of the Rheumatic Diseases. 79:675.1-676
Background:Distinguishing primary NPSLE (neuropsychiatric systemic lupus erythematosus) from secondary causes remains challenging (1). Attribution models were developed in order to aim clinicians in correct classification of NPSLE cases (2).Objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::168c5b95818ee7b96a277d4c5e59aeb7
https://doi.org/10.1136/annrheumdis-2020-eular.2470
https://doi.org/10.1136/annrheumdis-2020-eular.2470
Publikováno v:
Annals of agricultural and environmental medicine : AAEM. 25(2)
Hematologic disorders, including thrombocytopenia, are a common symptom of systemic lupus - Systemic Lupus Erythematosus (SLE). An important diagnostic and therapeutic issue is the severe and recurrent thrombocytopenia resistant to standard treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cee3816d4c11f8b45a068e646874c12
https://pubmed.ncbi.nlm.nih.gov/29936821
https://pubmed.ncbi.nlm.nih.gov/29936821
Autor:
M Sochocka-Bykowska, M Szarecka, Zofia Kiełbik, Mariusz Puszczewicz, A. Bielinska, Marzena Olesińska, Piotr Leszczyński, J. Kowalska-Majka, W Lepiarz-Rusek, K. Pawlak-Bus, J Zajdel, T Migas-Kukla, M Falenta-Hitnarowicz, Wojciech Romanowski, Anna Felis-Giemza, Małgorzata Tłustochowicz, Mariusz Korkosz, Maria Majdan, L. Szymczak-Bartz, I Rosmus-Kuczia, J. Bucka, Piotr Wiland, G Rozwadowski, J. Lewandowicz, M Majewski, Anna Kotulska, Eugeniusz J. Kucharz, Magdalena Kopeć-Mędrek, J Swikszcz-Gniadek, Zbigniew Zdrojewski, K Smolik, B Chara, B Luberda
Publikováno v:
Abstracts Accepted for Publication.
Background Biologics are still considered by patients as a new and partially enigmatic tool for management of rheumatic diseases. Objectives The study was designed to evaluate educational needs and sources of knowledge in patients with rheumatic dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83ef69c3e2e57631036f7925e6e10875
https://doi.org/10.1136/annrheumdis-2017-eular.2999
https://doi.org/10.1136/annrheumdis-2017-eular.2999
Publikováno v:
Abstracts Accepted for Publication.
Background Neuropsychiatric systemic lupus erythematosus (NPSLE) is defined as wide range of neurological and psychiatric symptoms due to inflammation and ischemic processes. It is difficult to recognize primary NPSLE because of multiple central and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f8a9d151b6403b17bbe1e0b0fbdff72
https://doi.org/10.1136/annrheumdis-2017-eular.4265
https://doi.org/10.1136/annrheumdis-2017-eular.4265
Autor:
K. Pawlak-Bus, Piotr Leszczyński
Publikováno v:
Abstracts Accepted for Publication.
Background Nowadays the lupus treatment strategy is based on background therapy, immunosuppressive drugs and glucocorticoids (GC). Using minimal effective dose of GC only in flares is a recomandation for preventing complications which increase mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7620d30cc6eafbcf66437459c65e016a
https://doi.org/10.1136/annrheumdis-2017-eular.5400
https://doi.org/10.1136/annrheumdis-2017-eular.5400
Autor:
P Leszczynski, K Pawlak-Bus
Publikováno v:
Poster Session.
Background and aims To evaluate clinical and immunological remission according to Systemic Lupus Erythematosus Disease Activity Index assessed by SLEDAI (version 2000) (Gladman et al , 2002). Methods We observed clinical response to standard treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a88689926e93077bff9acc959096df2
https://doi.org/10.1136/lupus-2017-000215.377
https://doi.org/10.1136/lupus-2017-000215.377
Autor:
Piotr Leszczyński, K. Pawlak-Bus
Publikováno v:
Rheumatology International
Vocal cords palsy is a rare complication in the course of systemic lupus erythematosus (SLE). A 38-year-old female patient with a history of SLE presented with chronic voice hoarseness resistant to standard treatment. High levels of antinuclear antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ab13a7aa75e19e07c66f233ca2cab3
https://doi.org/10.1007/s00296-012-2615-x
https://doi.org/10.1007/s00296-012-2615-x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.